20 June 2013
Keywords: s-p, takes, 150m, charge, restates, earnings, drug
Article | 03 March 2003
US drug major Schering-Plough has revised its fourth-quarter andfull-year 2002 earnings downwards after the company elected to take a
further $150 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2003
19 June 2013
© 2013 thepharmaletter.com